Tuesday, June 7, 2022
- 7:00pm-8:00pm
-
Outcomes of Living Donor Liver Transplant Using Low Graft Recipient Weight Ratio (GRWR ≤ 0.8)
Liver: Living Donor Liver Transplant and Partial Grafts • Hynes Halls C & D
- 7:00pm-8:00pm
-
Outcomes of Very Small Pediatric Donor Kidneys Utilizing Belatacept-Based Immunosuppression in Adult Recipients
Kidney Immunosuppression: Novel Regimens and Drug Minimization • Hynes Halls C & D
- 7:00pm-8:00pm
-
Overexpression of Human Ectonucleoside Triphosphate Diphosphohydrolase 1 (entpd1; Hcd39) Did Not Afford Significant Protection on Porcine Endothelial Cells
Xenotransplantation • Hynes Halls C & D
- 7:00pm-8:00pm
-
Patient Reported Outcomes Following Renal Transplantation: The Future of Holistic Post-Transplant Care
Psychosocial and Treatment Adherence • Hynes Halls C & D
- 7:00pm-8:00pm
-
PCR-Enhanced Performance Characteristics of TruGraf Gene Expression Profile in Kidney Transplant
Biomarkers: Clinical Outcomes • Hynes Halls C & D
- 7:00pm-8:00pm
-
Perioperative Management of Live Donor Liver Transplantation: National Survey Results
Liver: Living Donor Liver Transplant and Partial Grafts • Hynes Halls C & D
- 7:00pm-8:00pm
-
Peripheral Blood Immune Cell Profiles of Corneal Transplant with and without Acute Rejection
Biomarkers: Clinical Outcomes • Hynes Halls C & D
- 7:00pm-8:00pm
-
Phenotypes of Non-Citizen Kidney Transplant Recipients in the United States by Machine Learning Consensus Clustering
Health Equity and Access • Hynes Halls C & D
- 7:00pm-8:00pm
-
Plasma Donor-Derived Cell-Free DNA Longitudinal Kinetics After Kidney Transplantation in Children
Biomarkers: Clinical Outcomes • Hynes Halls C & D
- 7:00pm-8:00pm
-
Plasma Galectin-3 is Predictive of Post-Transplant Infection in Pediatric Liver Transplant Recipients
Biomarkers: Clinical Outcomes • Hynes Halls C & D
- «Previous Page
- 1
- …
- 40
- 41
- 42
- 43
- 44
- …
- 52
- Next Page»